- $2.91bn
- $1.93bn
- $665.07m
- 76
- 33
- 87
- 71
2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 781 | 389 | 514 | 555 | 665 |
Cost of Revenue | |||||
Gross Profit | 316 | 172 | 244 | 256 | 263 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 749 | 425 | 545 | 581 | 738 |
Operating Profit | 31.7 | -36.6 | -31.1 | -25.4 | -73.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.44 | -40.3 | -49 | -9.94 | -30.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16.5 | -26.4 | -28.9 | -11.3 | -12.9 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 437 | 64.9 | 111 | 2,133 | -14.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 437 | 64.9 | 111 | 2,133 | -14.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.434 | -0.348 | -0.204 | -0.139 | 0.034 |
Dividends per Share |